Skip to main navigation
Skip to search
Skip to main content
Arizona Board of Regents Home
Search content at Arizona Board of Regents
Home
Profiles
Departments and Centers
Scholarly Works
Grants
Activities
Equipment
Datasets
Press/Media
Prizes
Lipid metabolism and control in nonalcoholic fatty liver disease
Phunchai Charatcharoenwitthaya
, Keith Lindor
Executive Vice President and Provost, Office of the (EVPP)
Health Solutions, College of (CHS)
Knowledge Enterprise (KE)
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
4
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lipid metabolism and control in nonalcoholic fatty liver disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lipid Metabolism
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Lipid Control
100%
Liver
42%
Triglycerides
28%
Insulin Resistance
28%
Hepatic Fat
28%
Putative Drug Targets
14%
Clinical Data
14%
Epidemiological Data
14%
Metabolic Syndrome
14%
Whole-body
14%
Hepatic Steatosis
14%
Obesity Diabetes
14%
Biochemical Data
14%
Metabolic Status
14%
Hepatocytes
14%
Metabolic Abnormalities
14%
Obesity Resistance
14%
Disease Spectrum
14%
Cirrhosis
14%
Low-density Lipoprotein
14%
Nonalcoholic Steatohepatitis
14%
Western World
14%
Triglyceride Metabolism
14%
Diabetic Dyslipidemia
14%
Plasma Fatty Acids
14%
Hepatic Lipotoxicity
14%
Hepatic Manifestations
14%
Simple Steatosis
14%
Intermediate Lesions
14%
Liver Condition
14%
Biochemistry, Genetics and Molecular Biology
Triglyceride
100%
Lipid Metabolism
100%
Insulin Resistance
50%
Metabolic Pathway
25%
Dyslipidemia
25%
Hepatocyte
25%
Fatty Acid Blood Level
25%
Lipotoxicity
25%
Very Low-Density Lipoprotein
25%